{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T18:06:04Z","timestamp":1692554764010},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1963,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n        <jats:p>Androisoxazole, 17\u03b1-methylandrost-4-en-17\u03b2-ol[2,3-d]isoxazole, 17\u03b1-ethyl-19-nor-estra-4-en-17\u03b2-ol and testosterone were evaluated experimentally for anabolic activity by means of nitrogen balance studies and for androgenic activity on the basis of increase weight of the ventral prostate gland in a 10-day assay. Under these conditions their anabolic:androgenic activities relative to methyltestosterone (= 1.0) and ratios were: androisoxazole (1.55\/0.22) 7.0, methylandrostenol-isoxazole (1.2\/0.15) 8.0, ethylestrenol (1.7\/0.21) 8.1 and, of historical interest, testosterone (0.38\/0.57) 0.67. The first three agents thus are intermediate in degree of dissociation of anabolic and androgenic properties between methyltestosterone and the more promising isoxazole-conjugated and pyrazole-conjugated (stanozolol) agents discussed previously.<\/jats:p>","DOI":"10.1530\/acta.0.0440490","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T20:29:45Z","timestamp":1229372985000},"page":"490-498","update-policy":"http:\/\/dx.doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":11,"title":["RELATIVE ORAL ANABOLIC TO ANDROGENIC ACTIVITY RATIOS OF ANDROISOXAZOLE, ETHYLESTRENOL, METHYLANDROSTENOLISOXAZOLE AND TESTOSTERONE"],"prefix":"10.1093","volume":"44","author":[{"given":"Aaron","family":"Arnold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon O.","family":"Potts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur L.","family":"Beyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["Acta Endocrinologica"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/44\/4\/acta_44_4_002.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/44\/4\/acta_44_4_002.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:22:50Z","timestamp":1676391770000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/44\/4\/490\/6955446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1963,12]]},"references-count":0,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/acta.0.0440490","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1963,12]]}}}